loadpatents
name:-0.016384124755859
name:-0.011847019195557
name:-0.0086441040039062
Sturdivant; Jill M. Patent Filings

Sturdivant; Jill M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Sturdivant; Jill M..The latest application filed is for "ophthalmic compositions".

Company Profile
8.10.16
  • Sturdivant; Jill M. - Chapel Hill NC
  • Sturdivant; Jill M. - Baltimore MD
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Ophthalmic Compositions
App 20220304995 - Lin; Cheng-Wen ;   et al.
2022-09-29
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
Grant 11,427,563 - deLong , et al. August 30, 2
2022-08-30
Ophthalmic compositions
Grant 11,389,441 - Lin , et al. July 19, 2
2022-07-19
Mono-(acid) Salts Of 6-aminoisoquinolines And Uses Thereof
App 20220144778 - deLong; Mitchell A. ;   et al.
2022-05-12
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
Grant 11,312,700 - deLong , et al. April 26, 2
2022-04-26
Isoquinoline-steroid Conjugates And Uses Thereof
App 20210300874 - deLong; Mitchell A. ;   et al.
2021-09-30
Compounds, compositions and methods for treatment of myopia
Grant 11,117,869 - Carlson , et al. September 14, 2
2021-09-14
Isoquinoline-steroid conjugates and uses thereof
Grant 11,059,789 - deLong , et al. July 13, 2
2021-07-13
Amino-benzoisothiazole And Amino-benzoisothiadiazole Amide Compounds
App 20210087184 - deLong; Mitchell A. ;   et al.
2021-03-25
Aryl Cyclopropyl-amino-isoquinolinyl Amide Compounds
App 20210002253 - deLong; Mitchell A. ;   et al.
2021-01-07
Aryl cyclopropyl-amino-isoquinolinyl amide compounds
Grant 10,858,339 - deLong , et al. December 8, 2
2020-12-08
Aryl Cyclopropyl-amino-isoquinolinyl Amide Compounds
App 20200102290 - deLong; Mitchell A. ;   et al.
2020-04-02
Isoquinoline-steroid Conjugates And Uses Thereof
App 20200071275 - deLong; Mitchell A. ;   et al.
2020-03-05
Mono-(acid) Salts Of 6-aminoisoquinolines And Uses Thereof
App 20190322625 - deLong; Mitchell A. ;   et al.
2019-10-24
Dual mechanism inhibitors for the treatment of disease
Grant 10,316,029 - deLong , et al.
2019-06-11
Dual mechanism inhibitors for the treatment of disease
Grant 10,174,017 - deLong , et al. J
2019-01-08
Aryl Cyclopropyl-amino-isoquinolinyl Amide Compounds
App 20180327381 - deLong; Mitchell A. ;   et al.
2018-11-15
Dual Mechanism Inhibitors For The Treatment Of Disease
App 20180244666 - deLong; Mitchell A. ;   et al.
2018-08-30
Dual Mechanism Inhibitors For The Treatment Of Disease
App 20180215749 - deLong; Mitchell A. ;   et al.
2018-08-02
Beta-amino-isoquinolinyl amide compounds
Grant 9,963,432 - Sturdivant , et al. May 8, 2
2018-05-08
Ophthalmic Compositions
App 20180055833 - Lin; Cheng-Wen ;   et al.
2018-03-01
Beta-amino-isoquinolinyl Amide Compounds
App 20180050990 - Sturdivant; Jill M. ;   et al.
2018-02-22
Process For The Preparation Of Kinase Inhibitors And Intermediates Thereof
App 20170204065 - Sturdivant; Jill M.
2017-07-20
Process For The Preparation Of Kinase Inhibitors And Intermediates Thereof
App 20170137384 - Sturdivant; Jill M. ;   et al.
2017-05-18
Process for the preparation of kinase inhibitors and intermediates thereof
Grant 9,643,927 - Sturdivant , et al. May 9, 2
2017-05-09
Novel Compounds, Pharmaceutical Compositions Containing Same, and Methods of Use for Same
App 20090005435 - Sturdivant; Jill M. ;   et al.
2009-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed